Immunotherapy and Novel Treatment Strategies
Immunotherapy has transformed the treatment landscape for various neuroimmunological and neuroinfectious diseases. This session will examine current and emerging immunotherapeutic approaches, including monoclonal antibodies, immune checkpoint modulation, cytokine therapies, and cell-based treatments. It will also discuss novel drug delivery systems and combination therapies aimed at improving efficacy while minimizing side effects. Clinical trials, safety considerations, and treatment challenges will be reviewed to provide a balanced understanding of therapeutic advancements. The session emphasizes innovation in treatment design and the move toward more targeted, patient-specific therapeutic interventions.